We found that Gap26 treatment decreased the ROS level, inhibiting the ASK1-JNK/p38 signaling pathway and downregulating the apoptotic level of lung tissues, and finally improved the alveolar development of BPD rats. The gene discussed is MAP3K5; the disease is bronchopulmonary dysplasia.